|
Biochemical parameter
|
Reference intervals
|
25 mg/kg trial (n = 5)
|
85 mg/kg trial (n = 2)
|
|---|
|
BNW
|
SHNW
|
Mean
|
(Min–max)
|
Mean
|
(Min–max)
|
|---|
|
Sodium (mmol/l)
|
128.8–154.8
|
132.0–143.0
|
136.0a
|
129.0–146.0
|
136.9
|
135.0–140.0
|
|
Potassium (mmol/l)
|
1.4–17.1
|
4.1–10.8
|
5.4
|
4.0–8.4
|
5.4a
|
4.6–7.1
|
|
Chloride (mmol/l)
|
81.0–106.2
|
87.7–101.9
|
93.4
|
82.0–102.0
|
93.4
|
88.0–97.0
|
|
Bi-carbonate (mmol/l)
|
24.9–43.4
|
31.0–54.6
|
34.5a
|
27.0–47.0
|
32.2a
|
29.0–37.0
|
|
Sodium:potassium ratio
|
18.6–32.1
|
9.4–29.4
|
25.4a
|
16.4–35.3
|
25.7
|
19.0–29.8
|
|
Anion gap (mmol/l)
|
9.5–20.9
|
–
|
13.6a
|
2.0–23.2
|
16.7
|
12.5–19.6
|
|
Urea (mmol/l)
|
0.6–19.3
|
3.4–16.8
|
10.4
|
5.7–17.9
|
7.5
|
5.4–10.5
|
|
Creatinine (μmol/l)
|
34.0 – 278.8
|
72.4–307.6
|
80.0
|
40.0–130.0
|
91.0a
|
50.0–140.0
|
|
Phosphorous (mmol/l)
|
0.5–3.0
|
0.5–3.3
|
1.8
|
0.9–4.5
|
2.5a
|
1.8–5.1
|
|
Calcium (mmol/l)
|
1.9–3.4
|
2.3–2.7
|
2.6
|
2.3–3.5
|
2.5
|
2.3–2.7
|
|
Total protein (g/l)
|
46.1–86.5
|
54.5–72.5
|
62.2
|
57.0–70.0
|
58.8
|
54.0–64.0
|
|
Albumin (g/l)
|
20.2–38.2
|
22.0–43.0
|
34a
|
24.0–39.0
|
35.1
|
31.0–40.0
|
|
Globulin (g/lL)
|
16.9–53.6
|
17.0–37.8
|
28.2a
|
20.0–37.0
|
23.7
|
22.0–27.0
|
|
Albumin: globulin ratio
|
0.0–8.7
|
0.8–2.0
|
1.2a
|
0.7–1.9
|
1.5
|
1.2–1.7
|
|
Alkaline phosphatase (U/l)
|
0.0–1364.0
|
0.0–497.4
|
507.3a
|
242.0–884.0
|
920.7a
|
518.0–1339.0
|
|
Aspartate animotransferase (U/l)
|
0.0–186.8
|
4.0–73.8
|
60
|
42.0–111.0
|
59.8
|
41.0–100.0
|
|
Alanine aminotransferase (U/l)
|
0.0–162.6
|
0.4–93.0
|
35.2a
|
22.0–63.0
|
26.0
|
19.0–35.0
|
|
Creatine kinase (U/l)
|
0.0–5032.4
|
–
|
200.5
|
14.0–1593.0
|
463.3
|
26.0–2791.0
|
|
Cholesterol (mmol/l)
|
0.75–4.2
|
1.8–4.2
|
1.3
|
0.8–2.1
|
2.2a
|
1.4–2.9
|
- Parameters that deviated from reference intervals for bare-nosed or southern-hairy nosed wombats are highlighted in italics
- BNW, Bare-nosed wombat; min–max, minimum–maximum values; SHNW, southern hairy-nosed wombat
- aSignificant change observed over time-post fluralaner administration